Sunday, July 5, 2026

HomeGeneral NewsFDA approves first gene therapy for inherited deafness, shown to restore hearing...

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

- Advertisement -

  • Drug name: Otarmeni (lunsotogene parvec-cwha) by Regeneron
  • Approved April 23, 2026
  • Treats OTOF gene mutation deafness (~50 US babies/year)
  • Trial of 20 kids: 16 had hearing improvements at 5 months
  • 5 of 12 followed for ≥11 months had hearing essentially restored to normal
  • Effect lasted…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed